Interest rates at FDIC-insured banks remain at an all-time low. I've tracked rates for more than a decade on sites such as Magnify Money and Consumerism Commentary. Back in the day rates of 5.00% or more were common. It may take us years to get back to those levels.
Heres a question with an easy answer: Want to get rich?
Even if youre not the type to chase wealth, youd probably say yes to financial comfort. That feeling of not having to think about money or the more typical reality, stress over it is what were all really after.
Whether you ever get to breathe that sigh of relief depends not on the next lottery drawing....More>>>
The prescription-based market for treating constipation and irritable bowel syndrome in the last few years has become a near duopoly for two well-known industry names, Valeant Pharmaceuticals (NASDAQ: VRX) and Ironwood Pharmaceuticals (NASDAQ: IRWD). The former with its lead GI drug Xifaxan, treating OIC and IBS-D, while the latter with its star product Linzess, treating CIC and IBS-C.
America is a nation of borrowers, and while racking up debt can be dangerous at any age, it’s especially hazardous for those heading into retirement.
Because most seniors are behind on savings to begin with, carrying debt into retirement will only strain their already limited budget. Yet a growing number of households are kicking off their golden years with piles of debt —....More>>>
There is no doubt that tanker markets have entered the down cycle. Fortunately, the downturn does not seem too severe so far.
Weighed down by a large number of newbuilding deliveries, earnings of the main crude and product tanker classes had hit multi-year lows in the third quarter. But they recovered towards year-end as winter demand didn’t disappoint.
Starbucks (NASDAQ:SBUX) is an incredibly well-run business with impressive fundamentals as a direct result. That’s it; no need to discuss about the atmosphere in the stores, rewards programs, Pokemon Go, or even Chinese market penetration. That is the job of the management. The company has proven its worth year after year through its strong fundamental growth.
Highly paid corporate executives are often compensated with a complex web of bonuses, stock grants, insurance, pension plans and other financial instruments. Unfortunately, even though these company plans are their most valuable assets, many executives often wait years to develop a strategy to manage this wealth.
See Also: What to Do When You Have Employer Stock in Your Retirement Plan
On November 10, super-independent ConocoPhillips (NYSE:COP) hosted its annual analyst day and gave investors some guidance on what the firm plans on doing. After a solid Q3 report, the company was coming in with a strong hand to play. Last quarter, ConocoPhillips generated enough cash flow to cover both its capital expenditures and its dividend. Cash flow neutrality means its outspend headache is....More>>>
My wife grew up in a largish Catholic family. It’s no surprise that most of her childhood was spent in the back of their Oldsmobile station wagon shuttling to different local grocery stores (this was pre-wholesale club) to take advantage of various sale items advertised in newspaper ads and circulars. For consumer staples, price always matters. The same holds true when buying the stocks....More>>>
Yesterday, our Elite Opportunity Pronewsletter suggested the ProShares UltraShort Nasdaq Biotech (NASDAQ: BIS) and Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA: LABD) as ways to short biotech onshort termweakness in the sector, but our suggestion comes with a long termcaveat:
We’ve done well with our individual small biotech plays over the last several months. However, depending....More>>>
Most companies that have gone public this year are biotech firms and the first quarter marked the slowest start to IPOs since the last recession. In the current quarter, the fact that companies outside of biotech are eyeing or marching through the IPO door may be a sign of a slow thaw?
Big banks kick off earnings season Friday, and many analysts expect robust results after a post-election stock-trading frenzy that may have provided stronger revenue.
Lined up for tomorrow are Bank of America Corp(NYSE: BAC), JPMorgan Chase & Co. (NYSE: JPM), and Wells Fargo & Co (NYSE: WFC), and there’s plenty of enthusiasm going into the results. The financial sector overall....More>>>
U.S. equities were battered in the worst selloff since September 2016 as a series of developments have roiled President Trump over the past week — all related to former FBI director James Comey, Russia and former national security advisor Michael Flynn.